首页> 外文期刊>Neuro-Oncology >Imaging descriptors improve the predictive power of survival models for glioblastoma patients
【24h】

Imaging descriptors improve the predictive power of survival models for glioblastoma patients

机译:成像描述符可提高胶质母细胞瘤患者生存模型的预测能力

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Because effective prediction of survival time can be highly beneficial for the treatment of glioblas-toma patients, the relationship between survival time and multiple patient characteristics has been investigated. In this paper, we investigate whether the predictive power of a survival model based on clinical patient features improves when MRI features are also included in the model. Methods. The subjects in this study were 82 glioblastoma patients for whom clinical features as well as MR imaging exams were made available by The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA). Twenty-six imaging features in the available MR scans were assessed by radiologists from the TCGA Glioma Phenotype Research Group. We used multivariate Cox proportional hazards regression to construct 2 survival models: one that used 3 clinical features (age, gender, and KPS) as the covariates and 1 that used both the imaging features and the clinical features as the covariates. Then, we used 2 measures to compare the predictive performance of these 2 models: area under the receiver operating characteristic curve for the 1-year survival threshold and overall concordance index. To eliminate any positive performance estimation bias, we used leave-one-out cross-validation. Results. The performance of the model based on both clinical and imaging features was higher than the performance of the model based on only the clinical features, in terms of both area under the receiver operating characteristic curve (P < .01) and the overall concordance index (P < .01). Conclusions. Imaging features assessed using a controlled lexicon have additional predictive value compared with clinical features when predicting survival time in glioblastoma patients.
机译:背景。由于有效预测生存时间对胶质细胞瘤患者的治疗非常有益,因此已经研究了生存时间与多种患者特征之间的关系。在本文中,我们研究了当MRI特征也包括在模型中时,基于临床患者特征的生存模型的预测能力是否会提高。方法。这项研究的受试者是82例胶质母细胞瘤患者,他们的临床特征和MR影像学检查均由The Cancer Genome Atlas(TCGA)和The Cancer Imaging Archive(TCIA)提供。由TCGA胶质瘤表型研究小组的放射科医生评估了可用MR扫描中的26个成像特征。我们使用多元Cox比例风险回归构建了2个生存模型:一个使用3个临床特征(年龄,性别和KPS)作为协变量,另一个使用成像特征和临床特征作为协变量。然后,我们使用2种方法来比较这2种模型的预测性能:1年生存阈值和总体一致性指标的接收器工作特性曲线下的面积。为了消除任何积极的绩效评估偏差,我们使用了留一法交叉验证。结果。就接收器工作特征曲线下的面积(P <0.01)和总体一致性指数(P <0.01)而言,基于临床和影像学特征的模型的性能均高于仅基于临床特征的模型的性能。 P <.01)。结论。与预测胶质母细胞瘤患者生存时间的临床特征相比,使用受控词典评估的影像学特征具有附加的预测价值。

著录项

  • 来源
    《Neuro-Oncology》 |2013年第10期|1389-1394|共6页
  • 作者单位

    Department of Radiology, Duke University Medical Center, Durham, North Carolina;

    The Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina;

    Department of Electrical & Computer Engineering, Duke University, Durham, North Carolina Department of Electrical & Computer Engineering, Duke University, 130 Hudson Hall, Durham, NC 27708;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    glioblastoma; MRI; proportional hazards; survival analysis; VASARI;

    机译:胶质母细胞瘤核磁共振;比例危害;生存分析;瓦萨里;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号